Use of Ordinal Outcomes in Vascular Prevention Trials: Comparison With Binary Outcomes in Published Trials

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Stroke

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.107.509893PMID 18669897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

  2008cited by this paper
• Can We Improve the Statistical Analysis of Stroke Trials?: Statistical Reanalysis of Functional Outcomes in Stroke Trials

  2007cited by this paper
• An Introduction to the Bootstrap

  2007cited by this paper
• Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials

  2007cited by this paper
• Proportional odds logistic regression—effective means of dealing with limited uncertainty in dichotomizing clinical outcomes

  2006cited by this paper
• High-dose atorvastatin after stroke or transient ischemic attack.

  2006cited by this paper
• Aliskiren, a Novel Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Placebo-Like Tolerability in Japanese Patients with Hypertension

  2006cited by this paper
• High-dose atorvastatin after stroke or transient ischemic attack.

  2006cited by this paper
• Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure

  2006cited by this paper
• Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

  2006cited by this paper
• Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial

  2006cited by this paper
• Effects of Candesartan on Cardiovascular Outcomes in Japanese Hypertensive Patients

  2005cited by this paper
• Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri

  2005cited by this paper
• Effects of Clopidogrel and Aspirin in Combination Versus Aspirin Alone on Platelet Activation and Major Receptor Expression in Patients After Recent Ischemic Stroke: For the Plavix Use for Treatment of Stroke (PLUTO-Stroke) Trial

  2005cited by this paper
• Warfarin therapy and systolic hypertension in men with atrial fibrillation.

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES)

  2005cited by this paper
• Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.

  2005cited by this paper
• Decrease in Urinary Albumin Excretion Associated With the Normalization of Nocturnal Blood Pressure in Hypertensive Subjects

  2005cited by this paper
• Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients

  2005cited by this paper
• Long-Term Effectiveness of Extended-Release Nitrate for the Treatment of Systolic Hypertension

  2005cited by this paper
• HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.

  2004cited by this paper
• Sample Size Calculations in Acute Stroke Trials: A Systematic Review of Their Reporting, Characteristics, and Relationship With Outcome

  2004cited by this paper
• Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN).

  2004cited by this paper
• Protected carotid-artery stenting versus endarterectomy in high-risk patients.

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

  2004cited by this paper
• Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).

  2004cited by this paper
• Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

  2004cited by this paper
• Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation

  2004cited by this paper
• Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial.

  2004cited by this paper
• Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.

  2004cited by this paper
• Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial

  2004cited by this paper
• Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction: The TACIP Study: A Randomized, Double-Blind, Multicenter Trial

  2003cited by this paper
• Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

  2003cited by this paper
• A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women.

  2003cited by this paper
• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

  2003cited by this paper
• Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy

  2003cited by this paper
• Treatment of Isolated Systolic Hypertension: The SHELL Study Results

  2003cited by this paper
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack.

  2003cited by this paper
• Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study

  2003cited by this paper
• Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

  2003cited by this paper
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

  2003cited by this paper
• A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

  2003cited by this paper
• Dipyridamole in Stroke Prevention: Effect of Dipyridamole on Blood Pressure

  2003cited by this paper
• Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial

  2002cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial.

  2002cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• The Effect of 17β-Estradiol at Doses of 0.5, 1 and 2 mg Compared with Placebo on Early Postmenopausal Bone Loss in Hysterectomized Women

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

  2002cited by this paper
• Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.

  2002cited by this paper
• Effects of Transdermal Estradiol Delivered by a Matrix Patch on Bone Density in Hysterectomized, Postmenopausal Women: A 2-year Placebo-Controlled Trial

  2002cited by this paper
• Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women: Four-Year Results From the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Physiological advantages of cerebral blood flow during carotid endarterectomy under local anaesthesia. A randomised clinical trial.

  2002cited by this paper
• Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

  2002cited by this paper
• A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis Study

  2002cited by this paper
• The way I see it: House officers need formal career development

  2002cited by this paper
• Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial.

  2001cited by this paper
• Effect of Oral Postmenopausal Hormone Replacement on Progression of Atherosclerosis: A Randomized, Controlled Trial

  2001cited by this paper
• A clinical trial of estrogen-replacement therapy after ischemic stroke.

  2001cited by this paper
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

  2001cited by this paper
• Bootstrap Statistics of ECASS II Data: Just Another post hoc Analysis of a Negative Stroke Trial?

  2001cited by this paper
• Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

  2001cited by this paper
• A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.

  2001cited by this paper
• Effects of Hormone Replacement Therapy on Serum Lipids in Elderly Women

  2001cited by this paper
• Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study.

  2001cited by this paper
• Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators.

  2001cited by this paper
• TRIFLUSAL VERSUS ASPIRIN IN SECONDARY STROKE PREVENTION:RESULTS OF TACIP STUDY

  2001cited by this paper
• Correction of carotid augmentation index for heart rate in elderly essential hypertensives. ANBP2 Investigators. Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor- and Diuretic-Based Treatment of Hypertension in the Elderly.

  2001cited by this paper
• Estrogen in the Prevention of Atherosclerosis

  2001cited by this paper
• Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2. Evaluation of Losartan In The Elderly.

  2001cited by this paper
• Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.

  2001cited by this paper
• ESTROGEN AFTER ISCHEMIC STROKE: Effect of estrogen replacement on risk of recurrent stroke and death in the Women’s Estrogen for Stroke Trial (WEST)

  2001cited by this paper
• The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group.

  2000cited by this paper
• Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

  2000cited by this paper
• The EWA (Estrogen in Women with Atherosclerosis) Study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins

  2000cited by this paper
• RANDOMIZED DOUBLE-BLIND COMPARISON OF A CALCIUM CHANNEL BLOCKER AND A DIURETIC IN ELDERLY HYPERTENSIVES : A FINAL RESULT OF THE NATIONAL INTERVENTIONAL COOPERATIVE STUDY IN ELDERLY HYPERTENSION (NICS-EH)

  2000cited by this paper
• Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial

  2000cited by this paper
• Increased Risk of Recurrent Venous Thromboembolism during Hormone Replacement Therapy

  2000cited by this paper
• Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

  2000cited by this paper
• Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study.

  2000cited by this paper
• Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.

  2000cited by this paper
• Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

  2000cited by this paper
• Effect of Low-Dose Continuous Estrogen and Progesterone Therapy with Calcium and Vitamin D on Bone in Elderly Women

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease.

  2000cited by this paper
• Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)

  2000cited by this paper
• Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events

  2000cited by this paper
• Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril.

  2000cited by this paper
• Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group.

  2000cited by this paper
• Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

  2000cited by this paper
• Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial.

  2000cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper

• Lessons from the PROTECT-CH COVID-19 platform trial in care homes.

  2025cites this paper
• Statistical analyses of ordinal outcomes in randomised controlled trials: a scoping review

  2024cites this paper
• Biocompatibility and Bone Regeneration by Shape Memory Polymer Scaffolds.

  2024cites this paper
• Comparison of paired ordinal data with mis-classification and covariates adjustment

  2024cites this paper
• Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)

  2024cites this paper
• Multiple assessments of non‐inferiority trials with ordinal endpoints

  2023cites this paper
• Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia

  2023cites this paper
• Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure

  2023cites this paper
• Statistical analyses of ordinal outcomes in randomised controlled trials: protocol for a scoping review

  2022cites this paper
• Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)

  2022cites this paper
• Dietary nitrate supplementation for preventing and reducing the severity of winter infections, including COVID-19, in care homes (BEET-Winter): a randomised placebo-controlled feasibility trial

  2022cites this paper
• Hematoma Expansion Shift Analysis to Assess Acute Intracerebral Hemorrhage Treatments

  2021cites this paper
• Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials

  2021cites this paper
• Recurrent time‐to‐event models with ordinal outcomes

  2020cites this paper
• Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

  2020cites this paper
• Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial

  2020cites this paper
• Comparison of an ordinal endpoint to time-to-event, longitudinal, and binary endpoints for use in evaluating treatments for severe influenza requiring hospitalization

  2019cites this paper
• Clinical Trials for Traumatic Brain Injury: Designs and Challenges

  2018cites this paper
• Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.

  2018cites this paper
• Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.

  2018cites this paper
• Ordinal vs dichotomous analyses of modified Rankin Scale, 5-year outcome, and cost of stroke

  2018influential citation
• The effect of different combinations of vascular, dependency and cognitive endpoints on the sample size required to detect a treatment effect in trials of treatments to improve outcome after lacunar and non-lacunar ischaemic stroke

  2017cites this paper
• Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization

  2017cites this paper
• Sample size calculations for cluster randomised trials, with a focus on ordinal outcomes.

  2016cites this paper
• METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research

  2016cites this paper
• Edinburgh Research Explorer METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration. An initiative of the Joint Programme for Neurodegenerative Disease research

  2016cites this paper
• Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation.

  2016influential citation
• Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST)

  2016influential citation
• Effects of blood pressure lowering treatment in acute stroke. Secondary analyses of the Scandinavian Candesartan Acute Stroke Trial

  2015cites this paper
• Safety and efficacy of intensive vs. guideline antiplatelet therapy in high‐risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)

  2015cites this paper
• Effects of Candesartan in Acute Stroke on Vascular Events during Long-Term Follow-up: Results from the Scandinavian Candesartan Acute Stroke Trial (SCAST)

  2015cites this paper
• Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial

  2014cites this paper
• Effect Size Measures and Their Relationships in Stroke Studies

  2014cites this paper
• Random Forests for Ordinal Response Data: Prediction and Variable Selection

  2014cites this paper
• Analysis of the compliance and the related influence factors in the follow-up process of surveillance for Creutzfeldt-Jakob disease in China

  2014cites this paper
• Testing Devices for the Prevention and Treatment of Stroke and its Complications

  2014cites this paper
• The power of more than one.

  2013cites this paper
• Infarct Volume Predicts Delayed Recovery in Patients with Subarachnoid Hemorrhage and Severe Neurological Deficits

  2013cites this paper
• A Unified Framework for the Comparison of Treatments with Ordinal Responses

  2013cites this paper
• Acute treatment and prevention of stroke

  2012cites this paper
• Impact of GOS Misclassification on Ordinal Outcome Analysis of Traumatic Brain Injury Clinical Trials

  2012cites this paper
• Efficient analysis of ordinal data from clinical trials in head injury

  2012cites this paper
• Statistical Analysis of the Primary Outcome in Acute Stroke Trials

  2012cites this paper
• Calculation of Numbers-Needed-To-Treat in Parallel Group Trials Assessing Ordinal Outcomes: Case Examples from Acute Stroke and Stroke Prevention

  2011cites this paper
• The relative efficiency of time-to-threshold and rate of change in longitudinal data.

  2011cites this paper
• Blood pressure reduction and cardiovascular prevention: meta-regression using ordered categorical (ordinal) event data

  2010cites this paper
• Sensitivity analysis - the effects of Glasgow Outcome Scale misclassification on traumatic brain injury clinical trials

  2010cites this paper
• Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke: PRoFESS Subgroup Analysis

  2010cites this paper
• Systematic Reviews as a Tool for Planning and Interpreting Trials

  2009cites this paper
• Effect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic Stroke: A PRoFESS Subgroup Analysis

  2009cites this paper
• A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility

  2008cites this paper
• Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis

  2008cites this paper